Pfenex to Participate in the William Blair Growth Stock Conference
June 05 2020 - 8:00AM
Pfenex Inc. (NYSE American: PFNX) announced today that Eef
Schimmelpennink, President and Chief Executive Officer, will
participate in a fire side chat at the William Blair Growth Stock
Conference on June 9, 2020. The discussion will be virtual
and accessible at http://www.wsw.com/webcast/blair56/pfnx.
Presentation Details: |
Date: |
Tuesday, June
9, 2020 |
Time: |
9:20 am – 9:50 am Central Time (7:20 am – 7:50 am Pacific
Time) |
Link: |
http://www.wsw.com/webcast/blair56/pfnx |
Interested parties can access the live audio webcast and archive
from the Investors Section of Pfenex's website at
www.pfenex.com.
About Pfenex Inc.Pfenex is a development and
licensing biotechnology company focused on leveraging its Pfenex
Expression Technology® to develop and improve protein therapies for
unmet patient needs. Using the patented Pfenex Expression
Technology platform, Pfenex has created an advanced pipeline of
potential therapeutic equivalents, and vaccines. Pfenex’s lead
product candidate is PF708, a therapeutic equivalent candidate to
Forteo® (teriparatide injection). PF708 has been approved in the
U.S. for the treatment of osteoporosis in certain patients at high
risk for fracture, and marketing authorization applications are
pending in other jurisdictions. In addition, Pfenex is developing
hematology/oncology products in collaboration with Jazz
Pharmaceuticals, including PF743, a recombinant crisantaspase, and
PF745, a recombinant crisantaspase with half-life extension
technology. Pfenex also uses its Pfenex Expression Technology
platform to produce CRM197, a diphtheria toxoid carrier protein
used in prophylactic and therapeutic vaccines.
Pfenex investors and others should note that Pfenex announces
material information to the public about Pfenex through a variety
of means, including its website (http://www.pfenex.com/), its
investor relations website (http://pfenex.investorroom.com/), press
releases, SEC filings, public conference calls, corporate Twitter
account (https://twitter.com/pfenex), Facebook page
(https://www.facebook.com/Pfenex-Inc-105908276167776/timeline/),
and LinkedIn page (https://www.linkedin.com/company/pfenex-inc) in
order to achieve broad, non-exclusionary distribution of
information to the public and to comply with its disclosure
obligations under Regulation FD. Pfenex encourages its investors
and others to monitor and review the information Pfenex makes
public in these locations as such information could be deemed to be
material information. Please note that this list may be updated
from time to time.
Company
Contact:investorrelations@pfenex.com
Pfenex (AMEX:PFNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfenex (AMEX:PFNX)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Pfenex Inc (American Stock Exchange): 0 recent articles
More News Articles